Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.

Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc.,
                           and Array BioPharma Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, October 4, 2013

LONDON, October 4, 2013 /PRNewswire/ --

The U.S. equity market posted losses on Thursday, October 03, 2013. The S&P
500 ended the day at 1,678.66, down 0.90%; the Dow Jones Industrial Average
closed at 14,996.48, down 0.90%; and the NASDAQ Composite finished at
3,774.34, down 1.07%. Shares in the healthcare sector mostly edged lower,
tracking losses in the broader market. The major movers in the sector included
Johnson & Johnson (NYSE: JNJ), Mylan Inc. (NASDAQ: MYL), Brookdale Senior
Living Inc. (NYSE: BKD), and Array Biopharma Inc. (NASDAQ: ARRY).
AAAResearchReports.com has released full comprehensive research on JNJ, MYL,
BKD, and ARRY. These free technical analyses can be downloaded by signing up
at:

http://www.aaaresearchreports.com/register/ 

Shares in Johnson & Johnson edged lower on Thursday, extending losses from the
previous trading session. The company's shares oscillated between $86.28 and
$87.40 before finishing the day 0.81% lower at $86.58. A total of 7.72 million
shares were traded, which is below the daily average volume of 8.71 million.
Despite Thursday's losses, Johnson & Johnson's stock has advanced 0.19% in the
last one month, compared to a gain of 2.37% in the S&P 500 during the same
period. Additionally, the company's shares are trading below its 50-day and
200-day moving averages of $88.31 and $86.81, respectively. Download free
report on JNJ upon registration at:

http://www.AAAResearchReports.com/JNJ100413.pdf 

On Thursday, Mylan Inc.'s stock rose sharply, hitting a new 52-week high of
$40.22. The company's shares closed the day at $39.99, up 1.27% from the
previous day's price of $39.49. A total of 6.33 million shares were traded,
which is above the daily average volume of 4.11 million. Mylan Inc.'s shares
have rallied 11.99% in the last one month and 31.24% in the previous three
months, outperforming the S&P 500 which has gained 2.37% and 3.92% during the
respective periods. Furthermore, the company's stock is currently trading
above its 50-day and 200-day moving averages of $37.09 and $32.46,
respectively. MYL technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/MYL100413.pdf 

Brookdale Senior Living Inc.'s shares fell sharply on Thursday, extending
their losses from the previous trading session. The company's shares
vacillated between $26.00 and $26.85 before finishing the day 2.02% lower at
$26.18. A total of 1.81 million shares were traded, which is above the daily
average volume of 1.24 million. Despite Thursday's sharp decline, the
company's shares have gained 4.76% in the last one month, outperforming the
S&P 500 which has advanced 2.37% during the same period. Additionally,
Brookdale Senior Living Inc.'s stock is trading below its 50-day and 200-day
moving averages of $26.25 and $27.46, respectively. The free report on BKD can
be downloaded by signing up now at:

http://www.AAAResearchReports.com/BKD100413.pdf 

Shares in Array Biopharma Inc. fell by 0.15% on Thursday, reversing some of
the gains from the previous trading session. The company's shares closed the
day at $6.58, after fluctuating between $6.44 and $6.66. A total of 2.74
million shares were traded, which is above the daily average volume of 1.90
million. Despite Thursday's losses, the company's shares have surged 13.25% in
the last one month and 34.01% in the previous three months, outperforming the
S&P 500 which has gained 2.37% and 3.92% during the respective periods.
Furthermore, Array Biopharma Inc.'s stock is trading above its 50-day and
200-day moving averages of $6.05 and $5.59, respectively. A free report on
ARRY can be accessed by registering at:

http://www.AAAResearchReports.com/ARRY100413.pdf 

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

AAAresearchreports.com

SOURCE AAA Research Reports

Contact: +1(646)396-9126, Peter F. Jones, info@aaaresearchreports.com
 
Press spacebar to pause and continue. Press esc to stop.